Showing results (11-20 of 195) with videos related to
Sort By:
Pageof 20
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 17, 1998
[Prevention of thrombosis in medical patients--documentation is missing]A Johansen, U AbildgaardTidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 30, 1995
[Antithrombotic therapy in cerebrovascular disorders]T Dahl, U AbildgaardUgeskrift for Laeger|November 6, 1989
[Unnoticed loss of renal function during treatment with angiotensin I converting enzyme inhibitor. A new risk in patients with unrecognized unilateral stenosis of the renal artery]J Tingleff, S StrandgaardThrombosis and Haemostasis|June 30, 1976
On the value of the activated partial thrombo-plastin time (aptt) in monitoring heparin therapyA N Teien, U AbildgaardHaemostasis|January 1, 1991
Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastinP M Sandset, U AbildgaardThrombosis Research|September 15, 1984
Assay of unfractionated and LMW heparin with chromogenic substrates: twin methods with factor Xa and thrombinG F Handeland, U AbildgaardThrombosis Research|August 1, 1984
Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasmaU Abildgaard, M L LarsenHaemostasis|January 1, 1978
Antithrombin III: critical review of assay methods. Significance of variations in health and diseaseO R Odegård, U AbildgaardScandinavian Journal of Haematology|February 1, 1977
Antifactor Xa activity in thrombophilia. Studies in a family with Ar-III deficiencyO R Odegård, U AbildgaardThrombosis Research|January 15, 1987
Antithrombin antigen of high molecular weight associated with neoantigen in hemophilic plasma after factor IX concentrate therapyM B Hultin, U AbildgaardPageof 20